FRI0527 Safety and Efficacy of Tocilizumab in Methotrexate-Resistant form of Polyarticular-Course Juvenile Idiopathic Arthritis: Factors Associated with Achievement of Inactive Dis... von Kostik, M.M., Chikova, I.A., Isupova, E.A., Masalova, V.V., Dubko, M.F., Likhacheva, T.S., Snegireva, L.S., Kalashnikova, O.V., Chasnyk, V.G.

Volltext

THU0521 The Methotrexate Treatment can Prevent Uveitis Onset in Juvenile Idiopathic Arthritis: The Experience in Cohort with Increased Proportion of Methotrexate von Kostik, M.M., Gaidar, E.V., Dubko, M.F., Snegireva, L.S., Masalova, V.V., Chikova, I.A., Isupova, E.A., Nikitina, T.N., Serogodskaya, E.D., Kalashnikova, O.V., Ravelli, A., Chasnyk, V.G.

Volltext

FRI0551 Successful Treatment with TOCILIZUMAB Every 4 Weeks Distinguishes Low Disease Activity Group and Possibility to Achieve Drug-Free Remission in Patients with Systemic-Onset... von Kostik, M.M., Dubko, M.F., Masalova, V.V., Snegireva, L.S., Kornishina, T.L., Likhacheva, T.S., Chikova, I.A., Isupova, E.A., Kuchinskaya, E.M., Glebova, N.I., Buchinskaya, N.V., Gaidar, E.V., Kalashnikova, O.V., Chasnyk, V.G.

Volltext